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Cartilage reconstruction demands for biocompatible materials with
controlled biodegradation. Hydrogels, based on natural polymers,
fulﬁl these properties. Recently we have developed an injectable
chitosan-based hydrogel and have studied its biocompatibility
in vitro.
Chitosan was made water soluble by the covalent attachment of
glycolic acid with a graft ratio of 43. Phloretic acid was covalently
attached to the chitosan (graft ratio 10) and was used as the
crosslinking moiety. The hydrogels were prepared by enzymatic
crosslinking of the phenol moieties using hydrogen peroxide and
horseradish peroxidase. To evaluate biocompatibility, the polymer
was mixed with 5106mL bovine primary chondrocytes and ge-
lation was induced. Gelation occurred within 1 minute, under
mild conditions, and resulted in efﬁcient encapsulation of the cells.
The reaction was not associated with cytotoxicity. The gels were
cultured for 21 days in standard chondrocyte culture medium
and cell viability was evaluated using a live-dead assay at 1,7,14
and 21 days. There was no evidence for toxicity over time. Next,
we assessed the cell morphology using SEM-analysis. Results
show the presence of round chondrocyte-like cells and the pro-
duction of extracellular matrix. Biodegradation of the constructs
was assessed by weight loss quantiﬁcation, up to 28 days in culture.
Hydrogels with encapsulated chondrocytes degrade slower than
control.
In conclusion, our data show efﬁcient encapsulation of primary
chondrocytes in a chitosan-based hydrogel. The gelation reaction
was fast and not harmful for the cells. Cells retained a chondrocyte-
like morphology and produced extracellular matrix upto 21 days in
culture. This novel chitosan-based biodegradable matrix may have
application in cartilage reconstruction.
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Chitosan-based biomaterials proved to have promising character-
istics for wound dressing and skin regeneration. In the context of
developing new natural-based biomaterials for these applications,
chitosan and soybean-based biomaterials were proposed. These
materials were shown to be non cytotoxic and to impair human
leukocytes activation in vitro. Thus the goal of this study was to
evaluate the in vivo performance of chitosan/soy-based membranes
in the regeneration of partial thickness skin wounds. Excisional
skin wounds were created on the backs of rats and the healing
capacity of chitosan/soy-based membranes was assessed after 1
and 2 weeks. To promote impaired wound healing all rats were
injected with a steroid. After one week, membrane-dressed wounds
showed less granulation tissue formation and the wounds margins
were thinner than in untreated wounds (negative control). Fur-
thermore, in comparison to the positive control (Eppigard), the
chitosan/soy-based membranes were also able to reduce the wound
size and the thickness of the wound limits. A similar trend was
observed 2 weeks after the dressing. The membrane-dressed
wounds were almost closed, although with some contraction, and
with almost no granulation tissue. For both time periods there were
no signs of infection. The observed reepithelialization and en-
graftment between the regenerated tissue and the original skin
reinforces the suitability of the proposed chitosan/soy-based
membranes to be used in skin wound dressing.
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Background: Human embryonic stem cells (hESCs) have potential
to become cell source in tissue engineering applications upon
successful differentiation into speciﬁc cell types. With its limited
regenerative ability, cartilage is a particular candidate for skeletal
tissue engineering. This study investigates the differentiation of
hESCs into cartilaginous progenitors and the effects of TGF-b,
BMP-2 on the process at different time points.
Materials and Methods: Undifferentiated hESCs (HUES-9) were
characterized microscopically and by IHC. Pellet cultures were
established and differentiated for 28 days in hESC expansion
medium (ES-EM) supplemented with (1) 10 ng/ml TGF-b, (2)
50 ng/ml BMP-2, and (3) their combination. Cell pellets cultured in
ES-EM alone served as controls. At Day 1, 14 and 28, specimens
were ﬁxed and stained with Alcian Blue to detect glycosamino-
glycans. IHC and RT-PCRwere performed for Collagen I, Collagen
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